|
Accreditation |
2.0 AMA PRA Category 1 Credit(s)™.
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity may be submitted for American Osteopathic Association Continuing Medical Education credit in Category 2.
|
Target Audience |
This activity will be directed to rheumatologists, gastroenterologists, dermatologists, pulmonologists, nurse practitioners, physician assistants, and other health care professionals interested in or using biologic therapeutics in autoimmune and inflammatory disorders. |
Description |
This activity was presented at the Cleveland Clinic Richard J. Fasenmyer Center of Clinical Immunology Biologic Therapies for Autoimmune and Inflammatory Disease States Summit. The summit reviewed advances in biologic therapies for autoimmune diseases. |
Objectives |
At the conclusion of this activity, the participant will be able to:
- Explain genetic factors in IBD.
- Discuss the findings of the Consensus Conference of biologic therapy in IBD.
- Describe mechanisms in Crohn’s disease and ulcerative colitis.
|
Activity Director |
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
|
Faculty |
Jean-Paul Achkar, MD;
Bret Lashner, MD; Lloyd Mayer, MD |
Faculty Disclosure |
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Leonard Calabrese, DO |
|
Consulting, Teaching and Speaking: |
Genentech |
| |
Teaching and Speaking: |
Abbott; Amgen; Wyeth |
| |
| Bret Lashner, MD |
| |
Membership on Advisory Committee or Review Panels
|
Abbott; Elan; Procter & Gamble; Shire; UCB |
| |
Teaching & Speaking, Membership on Advisory
Committee or Review Panels |
Prometheus Labs |
| |
| Lloyd Mayer, MD |
| |
Consulting
|
Abbott; Centocor; UCB |
| |
Consulting & Independent Contractor |
Protein Design Labs |
The following faculty has indicated he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:
Jean-Paul Achkar, MD
|
| Estimated Time of Completion |
2 hours |
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:
 |
 |
 |
| Genentech and Biogen Idec. |
 |
 |
Gold Level

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education and UNITECH Communications®.
Contact Information | Privacy Policy | Disclaimer
Copyright © 2008 The Cleveland Clinic Foundation. All Rights Reserved. |